NASDAQ: ENSC 73.31%
Expected US Company Earnings on Tuesday, November 11th, 2025
NASDAQ: NGNE 31.15%
Neurogene Shares Rally on FDA Breakthrough Therapy Designation for Rett Syndrome Therapy
OTC: ACXIF 21.95%
Underperform Recommendation Issued On ACXIF By RBC Capital
NASDAQ: DLLL 42.51%
US Companies Moving the Markets, Evening edition Fri, Feb 27, 2026 as of 4:00 pm ET
NASDAQ: ONMD 72.9%
OneMedNet Stock Soars 90% Following Real-World Data Platform Launch
NYSE: KORE 77.39%
KORE Reports Third Quarter 2025 Results
NYSE: ENSC 31.15%
NYSE: NGNE 31.15%
NYSE: ACXIF 31.15%
NYSE: DLLL 31.15%
NYSE: ONMD 31.15%
